According to the TIMER database’s pan-cancer differential gene expression analysis, SLAMF8 was later found to be highly expressed in prostate cancer and various other cancers, as shown in Fig. 2B. To investigate the link between SLAMF8 expression and prostate cancer clinical characteristics, researchers categorized individuals into high and low groups using the median cut method. This evidence concerns the gene SLAMF8 and cancer.